News Image

Looking for growth without the hefty price tag? Consider NASDAQ:HALO.

By Mill Chart

Last update: Dec 16, 2024

Take a closer look at HALOZYME THERAPEUTICS INC (NASDAQ:HALO), an affordable growth stock uncovered by our stock screener. NASDAQ:HALO boasts strong growth prospects and excels in financial health indicators, all while maintaining a reasonable valuation. Let's break it down further.


Affordable Growth stocks image

Evaluating Growth: NASDAQ:HALO

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:HALO has received a 9 out of 10:

  • The Earnings Per Share has grown by an impressive 55.33% over the past year.
  • Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.64% on average per year.
  • Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 21.36%.
  • HALO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.42% yearly.
  • The Earnings Per Share is expected to grow by 25.94% on average over the next years. This is a very strong growth
  • HALO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.59% yearly.

Analyzing Valuation Metrics

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:HALO has achieved a 9 out of 10:

  • Based on the Price/Earnings ratio, HALO is valued cheaper than 97.70% of the companies in the same industry.
  • HALO is valuated cheaply when we compare the Price/Earnings ratio to 29.00, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 9.73 indicates a reasonable valuation of HALO.
  • Based on the Price/Forward Earnings ratio, HALO is valued cheaply inside the industry as 98.05% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.60, HALO is valued rather cheaply.
  • Based on the Enterprise Value to EBITDA ratio, HALO is valued cheaper than 97.17% of the companies in the same industry.
  • HALO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HALO is cheaper than 97.17% of the companies in the same industry.
  • HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of HALO may justify a higher PE ratio.
  • HALO's earnings are expected to grow with 32.04% in the coming years. This may justify a more expensive valuation.

Evaluating Health: NASDAQ:HALO

To gauge a stock's financial health, ChartMill utilizes a Health Rating on a scale of 0 to 10. This comprehensive evaluation encompasses liquidity and solvency, both in absolute terms and in comparison to industry peers. NASDAQ:HALO has earned a 7 out of 10:

  • HALO has an Altman-Z score of 4.23. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
  • HALO has a Altman-Z score of 4.23. This is in the better half of the industry: HALO outperforms 78.23% of its industry peers.
  • HALO has a debt to FCF ratio of 3.83. This is a good value and a sign of high solvency as HALO would need 3.83 years to pay back of all of its debts.
  • HALO's Debt to FCF ratio of 3.83 is amongst the best of the industry. HALO outperforms 94.16% of its industry peers.
  • A Current Ratio of 10.36 indicates that HALO has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 10.36, HALO belongs to the best of the industry, outperforming 82.30% of the companies in the same industry.
  • A Quick Ratio of 9.15 indicates that HALO has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 9.15, HALO is doing good in the industry, outperforming 78.23% of the companies in the same industry.

Exploring NASDAQ:HALO's Profitability

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:HALO, the assigned 7 is noteworthy for profitability:

  • Looking at the Return On Assets, with a value of 18.53%, HALO belongs to the top of the industry, outperforming 98.58% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 86.69%, HALO belongs to the top of the industry, outperforming 99.65% of the companies in the same industry.
  • HALO has a better Return On Invested Capital (19.23%) than 98.23% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 13.59%.
  • The last Return On Invested Capital (19.23%) for HALO is above the 3 year average (17.78%), which is a sign of increasing profitability.
  • The Profit Margin of HALO (41.43%) is better than 98.76% of its industry peers.
  • HALO has a better Operating Margin (50.35%) than 100.00% of its industry peers.
  • With an excellent Gross Margin value of 82.09%, HALO belongs to the best of the industry, outperforming 87.26% of the companies in the same industry.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of HALO contains the most current fundamental analsysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (12/20/2024, 7:19:13 PM)

After market: 46.96 0 (0%)

46.96

-0.36 (-0.76%)

Follow us for more